Acadia Healthcare (NASDAQ:ACHC) Stock Price Up 3.6% – What’s Next?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) rose 3.6% on Wednesday. The stock traded as high as $31.25 and last traded at $31.3290. 498,230 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 2,887,659 shares. The stock had previously closed at $30.23.

Wall Street Analysts Forecast Growth

ACHC has been the subject of several recent research reports. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, September 9th. Guggenheim raised their target price on Acadia Healthcare from $38.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 30th. UBS Group upped their price target on Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 9th. KeyCorp increased their price objective on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research report on Tuesday, July 14th. Finally, Barclays boosted their target price on shares of Acadia Healthcare from $25.00 to $32.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 30th. Eight analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $30.69.

Read Our Latest Stock Report on Acadia Healthcare

Acadia Healthcare Trading Down 2.0%

The stock has a market cap of $2.89 billion, a P/E ratio of -2.49, a price-to-earnings-growth ratio of 10.20 and a beta of 0.63. The firm’s 50 day simple moving average is $28.89 and its two-hundred day simple moving average is $27.90. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20.

Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last posted its earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%. The company had revenue of $865.84 million during the quarter, compared to analyst estimates of $844.19 million. During the same period in the prior year, the company earned $0.83 earnings per share. The business’s revenue was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, equities research analysts predict that Acadia Healthcare Company, Inc. will post 1.55 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in ACHC. Congress Asset Management Co. lifted its position in Acadia Healthcare by 20.8% in the 3rd quarter. Congress Asset Management Co. now owns 287,390 shares of the company’s stock worth $7,903,000 after buying an additional 49,418 shares in the last quarter. WINTON GROUP Ltd grew its stake in Acadia Healthcare by 1.4% in the 2nd quarter. WINTON GROUP Ltd now owns 255,451 shares of the company’s stock valued at $7,543,000 after buying an additional 3,449 shares during the last quarter. Integrated Wealth Concepts LLC acquired a new position in shares of Acadia Healthcare during the 2nd quarter worth about $79,000. Corient Private Wealth LP lifted its holdings in shares of Acadia Healthcare by 22.5% during the second quarter. Corient Private Wealth LP now owns 24,258 shares of the company’s stock worth $716,000 after buying an additional 4,459 shares during the last quarter. Finally, Braidwell LP raised its stake in Acadia Healthcare by 76.7% during the 2nd quarter. Braidwell LP now owns 1,141,477 shares of the company’s stock valued at $33,708,000 after purchasing an additional 495,577 shares during the last quarter.

About Acadia Healthcare

(Get Free Report)

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a provider of behavioral healthcare services. The company operates a network of psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics that provide care for individuals with mental health conditions, substance use disorders and other behavioral health needs.

Acadia’s services are designed for children, adolescents and adults and may include inpatient psychiatric treatment, addiction treatment, residential care, partial hospitalization and intensive outpatient programs.

Recommended Stories

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.